In March 2025, the company declared new programs for any direct-to-purchaser giving of its Wegovy weight loss drug. The company founded a fresh pharmacy, called NovoCare, which might charge consumers $499 every month for access to the drug, under half the price of the drug through other pharmaceutical distribution networks.[53]Other search engines